GEN Exclusives

More »

GEN News Highlights

More »
Mar 7, 2007

Five Indications Added to Lipitor Label

  • Pfizer’s anticholesterol drug, Lipitor, widely prescribed to reduce cardiovascular events in patients without heart disease, can now be used to treat at risk patients with established heart disease, according to the company.

    The FDA added five new indications to Lipitor. "These new indications are important since many patients who have heart disease remain at risk for another cardiovascular event, and now these indications broaden the means to reduce their risk," comments Dr. John C. LaRosa, president and professor of medicine at the State University of New York Downstate Medical Center in Brooklyn and Pfizer consultant.

    Lipitor is now approved to reduce the risk of nonfatal heart attacks, fatal and nonfatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?